AtriCure Stock Forward View - Simple Exponential Smoothing
| ATRC Stock | USD 36.95 0.82 2.17% |
AtriCure Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast AtriCure stock prices and determine the direction of AtriCure's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of AtriCure's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of AtriCure's share price is approaching 46. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling AtriCure, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Using AtriCure hype-based prediction, you can estimate the value of AtriCure from the perspective of AtriCure response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of AtriCure on the next trading day is expected to be 36.95 with a mean absolute deviation of 0.91 and the sum of the absolute errors of 55.22. AtriCure after-hype prediction price | USD 36.95 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of AtriCure to cross-verify your projections. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.AtriCure Additional Predictive Modules
Most predictive techniques to examine AtriCure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AtriCure using various technical indicators. When you analyze AtriCure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
AtriCure Simple Exponential Smoothing Price Forecast For the 31st of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of AtriCure on the next trading day is expected to be 36.95 with a mean absolute deviation of 0.91, mean absolute percentage error of 1.55, and the sum of the absolute errors of 55.22.Please note that although there have been many attempts to predict AtriCure Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that AtriCure's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
AtriCure Stock Forecast Pattern
| Backtest AtriCure | AtriCure Price Prediction | Buy or Sell Advice |
AtriCure Forecasted Value
In the context of forecasting AtriCure's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. AtriCure's downside and upside margins for the forecasting period are 33.59 and 40.31, respectively. We have considered AtriCure's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of AtriCure stock data series using in forecasting. Note that when a statistical model is used to represent AtriCure stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.5467 |
| Bias | Arithmetic mean of the errors | -0.0393 |
| MAD | Mean absolute deviation | 0.9052 |
| MAPE | Mean absolute percentage error | 0.024 |
| SAE | Sum of the absolute errors | 55.22 |
Predictive Modules for AtriCure
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AtriCure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AtriCure After-Hype Price Density Analysis
As far as predicting the price of AtriCure at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AtriCure or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AtriCure, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AtriCure Estimiated After-Hype Price Volatility
In the context of predicting AtriCure's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AtriCure's historical news coverage. AtriCure's after-hype downside and upside margins for the prediction period are 33.61 and 40.29, respectively. We have considered AtriCure's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AtriCure is very steady at this time. Analysis and calculation of next after-hype price of AtriCure is based on 3 months time horizon.
AtriCure Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as AtriCure is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AtriCure backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AtriCure, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 3.36 | 0.11 | 0.00 | 14 Events / Month | 7 Events / Month | In about 14 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
36.95 | 36.95 | 0.00 |
|
AtriCure Hype Timeline
AtriCure is presently traded for 36.95. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.0. AtriCure is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.19%. %. The volatility of related hype on AtriCure is about 30545.45%, with the expected price after the next announcement by competition of 36.95. About 97.0% of the company shares are held by institutions such as insurance companies. The book value of AtriCure was presently reported as 9.59. The company recorded a loss per share of 0.61. AtriCure last dividend was issued on the 30th of September 2010. Given the investment horizon of 90 days the next projected press release will be in about 14 days. Check out Historical Fundamental Analysis of AtriCure to cross-verify your projections. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.AtriCure Related Hype Analysis
Having access to credible news sources related to AtriCure's direct competition is more important than ever and may enhance your ability to predict AtriCure's future price movements. Getting to know how AtriCure's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AtriCure may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| QDEL | Quidel | (1.50) | 11 per month | 0.00 | (0.02) | 8.12 | (6.16) | 24.99 | |
| BLFS | BioLife Solutions | (0.02) | 19 per month | 0.00 | (0.14) | 3.61 | (4.11) | 13.90 | |
| KMTS | Kestra Medical Technologies | (0.13) | 17 per month | 0.00 | (0.02) | 4.59 | (7.02) | 20.54 | |
| AZTA | Azenta Inc | (0.02) | 2 per month | 1.76 | 0.13 | 3.81 | (2.89) | 22.17 | |
| TXG | 10X Genomics | 0.84 | 9 per month | 2.54 | 0.16 | 10.23 | (3.91) | 23.84 | |
| NVCR | Novocure | (0.09) | 27 per month | 0.00 | (0.05) | 4.95 | (4.90) | 14.06 | |
| XERS | Xeris Pharmaceuticals | (0.23) | 15 per month | 0.00 | (0.11) | 4.71 | (4.66) | 23.95 | |
| SEM | Select Medical Holdings | 0.04 | 15 per month | 1.02 | 0.05 | 2.25 | (1.70) | 13.50 | |
| LMAT | LeMaitre Vascular | 1.19 | 6 per month | 0.00 | (0.05) | 2.17 | (2.30) | 8.28 | |
| IMCR | Immunocore Holdings | (0.19) | 6 per month | 2.37 | (0.01) | 4.73 | (3.78) | 11.66 |
Other Forecasting Options for AtriCure
For every potential investor in AtriCure, whether a beginner or expert, AtriCure's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AtriCure Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AtriCure. Basic forecasting techniques help filter out the noise by identifying AtriCure's price trends.AtriCure Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AtriCure stock to make a market-neutral strategy. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AtriCure Market Strength Events
Market strength indicators help investors to evaluate how AtriCure stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AtriCure shares will generate the highest return on investment. By undertsting and applying AtriCure stock market strength indicators, traders can identify AtriCure entry and exit signals to maximize returns.
| Accumulation Distribution | 19537.74 | |||
| Daily Balance Of Power | (0.54) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 37.23 | |||
| Day Typical Price | 37.14 | |||
| Price Action Indicator | (0.69) | |||
| Period Momentum Indicator | (0.82) | |||
| Relative Strength Index | 46.44 |
AtriCure Risk Indicators
The analysis of AtriCure's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AtriCure's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting atricure stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.41 | |||
| Semi Deviation | 2.96 | |||
| Standard Deviation | 3.34 | |||
| Variance | 11.14 | |||
| Downside Variance | 10.26 | |||
| Semi Variance | 8.77 | |||
| Expected Short fall | (2.46) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for AtriCure
The number of cover stories for AtriCure depends on current market conditions and AtriCure's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AtriCure is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AtriCure's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AtriCure Short Properties
AtriCure's future price predictability will typically decrease when AtriCure's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AtriCure often depends not only on the future outlook of the potential AtriCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AtriCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47 M | |
| Cash And Short Term Investments | 122.7 M |
Check out Historical Fundamental Analysis of AtriCure to cross-verify your projections. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Stock sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value—what AtriCure's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.